Corticosteroids Are NOT Recommended for Streptococcal Pharyngitis
The IDSA guidelines explicitly recommend against adjunctive corticosteroid therapy for group A streptococcal pharyngitis 1. This is a clear, evidence-based recommendation that should guide your practice.
The Evidence Against Steroids
The 2012 IDSA guideline provides a weak recommendation with moderate-quality evidence against corticosteroid use 1. While research studies have shown that corticosteroids can reduce pain duration, the actual clinical benefit is minimal:
- Pain reduction is only about 5 hours on average 2
- Pain score improvement at 24 hours is only 0.9 points on a 0-10 scale 2
- The effect is so small that it doesn't justify routine use
Why This Matters
The guideline's position is based on several key concerns:
- Minimal clinical benefit: The approximately 5-hour reduction in throat pain duration is not clinically meaningful enough to warrant routine steroid use 1
- Lack of long-term safety data: Studies showing benefit have not included adequate long-term follow-up to assess potential adverse effects 1
- Unclear interaction with standard therapy: The effect of concomitant NSAIDs and acetaminophen (which ARE recommended) makes the added benefit of steroids even less clear 1
What You SHOULD Use Instead
For symptom management, use acetaminophen or NSAIDs (like ibuprofen) as adjunctive therapy 1. These have:
- Strong evidence for reducing fever and pain (strong recommendation, high-quality evidence)
- Well-established safety profiles
- No concerns about long-term complications
Avoid aspirin in children due to Reye syndrome risk 1.
Common Pitfall to Avoid
Don't be swayed by individual research studies showing modest benefit 3, 4. The guideline committee reviewed all available evidence and determined that the small reduction in symptoms does not justify routine corticosteroid use when weighed against potential risks and the availability of safer alternatives.